About Inflammatix
The Problem Inflammatix addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.
The Solution Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical In practice, Inflammatix centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.
Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Inflammatix is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.
Why it Matters
Inflammatix matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Inflammatix is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.
Funding Snapshot
- Series D • Khosla Ventures, $102M Series D in 2021
Hiring Roles
This company is actively hiring.
Meet the Founders
Inflammatix Team
Founder & CEO